Seroprevalence and correlates of SARS-CoV-2 neutralizing antibodies from a population-based study in Bonn, Germany

Population-based studies of SARS-CoV-2 seroprevalence are needed to understand levels of immunity and antibody dynamics. Here, the authors show that the seroprevalence in Bonn, Germany was low (<1%) following the first epidemic wave, and that neutralising antibodies waned within a few months.

Guardado en:

Detalles Bibliográficos
Autores principales:	N. Ahmad Aziz, Victor M. Corman, Antje K. C. Echterhoff, Marcel A. Müller, Anja Richter, Antonio Schmandke, Marie Luisa Schmidt, Thomas H. Schmidt, Folgerdiena M. de Vries, Christian Drosten, Monique M. B. Breteler
Formato:	article
Lenguaje:	EN
Publicado:	Nature Portfolio 2021
Materias:	Science Q
Acceso en línea:	https://doaj.org/article/e3f2cdd89cc949cdbd3d995965ba5c0d
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:e3f2cdd89cc949cdbd3d995965ba5c0d
record_format	dspace
spelling	oai:doaj.org-article:e3f2cdd89cc949cdbd3d995965ba5c0d2021-12-02T14:37:45ZSeroprevalence and correlates of SARS-CoV-2 neutralizing antibodies from a population-based study in Bonn, Germany10.1038/s41467-021-22351-52041-1723https://doaj.org/article/e3f2cdd89cc949cdbd3d995965ba5c0d2021-04-01T00:00:00Zhttps://doi.org/10.1038/s41467-021-22351-5https://doaj.org/toc/2041-1723Population-based studies of SARS-CoV-2 seroprevalence are needed to understand levels of immunity and antibody dynamics. Here, the authors show that the seroprevalence in Bonn, Germany was low (<1%) following the first epidemic wave, and that neutralising antibodies waned within a few months.N. Ahmad AzizVictor M. CormanAntje K. C. EchterhoffMarcel A. MüllerAnja RichterAntonio SchmandkeMarie Luisa SchmidtThomas H. SchmidtFolgerdiena M. de VriesChristian DrostenMonique M. B. BretelerNature PortfolioarticleScienceQENNature Communications, Vol 12, Iss 1, Pp 1-10 (2021)
institution	DOAJ
collection	DOAJ
language	EN
topic	Science Q
spellingShingle	Science Q N. Ahmad Aziz Victor M. Corman Antje K. C. Echterhoff Marcel A. Müller Anja Richter Antonio Schmandke Marie Luisa Schmidt Thomas H. Schmidt Folgerdiena M. de Vries Christian Drosten Monique M. B. Breteler Seroprevalence and correlates of SARS-CoV-2 neutralizing antibodies from a population-based study in Bonn, Germany
description	Population-based studies of SARS-CoV-2 seroprevalence are needed to understand levels of immunity and antibody dynamics. Here, the authors show that the seroprevalence in Bonn, Germany was low (<1%) following the first epidemic wave, and that neutralising antibodies waned within a few months.
format	article
author	N. Ahmad Aziz Victor M. Corman Antje K. C. Echterhoff Marcel A. Müller Anja Richter Antonio Schmandke Marie Luisa Schmidt Thomas H. Schmidt Folgerdiena M. de Vries Christian Drosten Monique M. B. Breteler
author_facet	N. Ahmad Aziz Victor M. Corman Antje K. C. Echterhoff Marcel A. Müller Anja Richter Antonio Schmandke Marie Luisa Schmidt Thomas H. Schmidt Folgerdiena M. de Vries Christian Drosten Monique M. B. Breteler
author_sort	N. Ahmad Aziz
title	Seroprevalence and correlates of SARS-CoV-2 neutralizing antibodies from a population-based study in Bonn, Germany
title_short	Seroprevalence and correlates of SARS-CoV-2 neutralizing antibodies from a population-based study in Bonn, Germany
title_full	Seroprevalence and correlates of SARS-CoV-2 neutralizing antibodies from a population-based study in Bonn, Germany
title_fullStr	Seroprevalence and correlates of SARS-CoV-2 neutralizing antibodies from a population-based study in Bonn, Germany
title_full_unstemmed	Seroprevalence and correlates of SARS-CoV-2 neutralizing antibodies from a population-based study in Bonn, Germany
title_sort	seroprevalence and correlates of sars-cov-2 neutralizing antibodies from a population-based study in bonn, germany
publisher	Nature Portfolio
publishDate	2021
url	https://doaj.org/article/e3f2cdd89cc949cdbd3d995965ba5c0d
work_keys_str_mv	AT nahmadaziz seroprevalenceandcorrelatesofsarscov2neutralizingantibodiesfromapopulationbasedstudyinbonngermany AT victormcorman seroprevalenceandcorrelatesofsarscov2neutralizingantibodiesfromapopulationbasedstudyinbonngermany AT antjekcechterhoff seroprevalenceandcorrelatesofsarscov2neutralizingantibodiesfromapopulationbasedstudyinbonngermany AT marcelamuller seroprevalenceandcorrelatesofsarscov2neutralizingantibodiesfromapopulationbasedstudyinbonngermany AT anjarichter seroprevalenceandcorrelatesofsarscov2neutralizingantibodiesfromapopulationbasedstudyinbonngermany AT antonioschmandke seroprevalenceandcorrelatesofsarscov2neutralizingantibodiesfromapopulationbasedstudyinbonngermany AT marieluisaschmidt seroprevalenceandcorrelatesofsarscov2neutralizingantibodiesfromapopulationbasedstudyinbonngermany AT thomashschmidt seroprevalenceandcorrelatesofsarscov2neutralizingantibodiesfromapopulationbasedstudyinbonngermany AT folgerdienamdevries seroprevalenceandcorrelatesofsarscov2neutralizingantibodiesfromapopulationbasedstudyinbonngermany AT christiandrosten seroprevalenceandcorrelatesofsarscov2neutralizingantibodiesfromapopulationbasedstudyinbonngermany AT moniquembbreteler seroprevalenceandcorrelatesofsarscov2neutralizingantibodiesfromapopulationbasedstudyinbonngermany
_version_	1718390984062009344

Seroprevalence and correlates of SARS-CoV-2 neutralizing antibodies from a population-based study in Bonn, Germany

Ejemplares similares